Clinical Trial Update: Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity [Phase 2]

View source ↗

Summary

A Phase 2a placebo-controlled trial evaluating VTX3232 alone or in combination with semaglutide for obesity has completed; the snippet does not provide the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• VTX3232
• semaglutide (semaglutide)

Snippet

Sponsor: Zomagen Biosciences Ltd. | Conditions: Obesity | Phase 2 | Status: COMPLETED